Muhamad Alhaj Moustafa, M.D., M.S.

  1. Hematologist
  2. Oncologist
  1. Saifi O, Breen WG, Lester SC, Rule WG, Stish BJ, Rosenthal A, Munoz J, Lin Y, Bansal R, Hathcock MA, Johnston PB, Ansell SM, Paludo J, Khurana A, Villasboas JC, Wang Y, Iqbal M, Alhaj Moustafa M, Murthy HS, Ayala E, Kharfan-Dabaja MA, Hoppe BS, Peterson JL. Outcomes of patients with R/R B-cell NHL and limited (<5 sites) pre-CART disease bridged with or without radiotherapy. Blood Adv. 2024 Sep 24; 8 (18):4877-4885
    View PubMed
  2. Plante MM, Wang J, Alhaj Moustafa M. 73-Year-Old Man With Worsening Hematuria. Mayo Clin Proc. 2024 Sep; 99 (9):1494-1499 Epub 2024 June 22
    View PubMed
  3. Wang TP, Ahn KW, Shadman M, Kaur M, Ahmed N, Bacher U, Cerny J, Chen A, Epperla N, Frigault M, Grover N, Haverkos B, Hill B, Hossain N, Iqbal M, Jain T, Krem MM, Maakaron J, Modi D, Alhaj Moustafa M, Riedell P, Savani B, Sica RA, Sureda A, Wudhikarn K, Herrera AF, Sauter C, Hamadani M, Jimenez Jimenez A. Chimeric antigen receptor T-cell infusion for large B-cell lymphoma in complete remission: a center for international blood and marrow transplant research analysis. Leukemia. 2024 Jul; 38 (7):1564-1569 Epub 2024 May 15
    View PubMed
  4. Moustafa MA, Ramdial JL, Tsalatsanis A, Khimani F, Dholaria B, Bojanini L, Brooks TR, Zain J, Bennani NN, Braunstein Z, Brammer JE, Beitinjaneh A, Jagadeesh D, Weng WK, Kumar A, Kharfan-Dabaja MA, Ahmed S, Murthy HS. A US Multicenter Collaborative Study on Outcomes of Hematopoietic Cell Transplantation in Hepatosplenic T-Cell Lymphoma. Transplant Cell Ther. 2024 May; 30 (5):516.e1-516.e10 Epub 2024 Feb 29
    View PubMed
  5. Khan SJ, Alhaj Moustafa M. CAR-T cell therapy: unravelling its potential in extra-nodal diffuse large B cell lymphoma. Chin Clin Oncol 2024 Apr; 13 (2):31 Epub 2024 Apr 18
    View PubMed
  6. Mosalem O, Pai T, Alqawasma M, Shaikh M, Li KD, Alhaj Moustafa M. Severe Cytokine Release Syndrome and Hemophagocytic Lymphohistiocytosis (HLH)-Like Syndrome Following Administration of Combined Brentuximab Vedotin and Nivolumab for Recurrent Classical Hodgkin Lymphoma: A Case Report. J Blood Med. 2024; 15:29-34 Epub 2024 Jan 24
    View PubMed
  7. Alhaj Moustafa M, Parrondo R, Abdulazeez MF, Roy V, Sher T, Alegria VR, Warsame RM, Fonseca R, Rasheed A, Gonsalves WI, Kourelis T, Kapoor P, Buadi FK, Dingli D, Hayman SR, Reeder CB, Chanan-Khan AA, Ailawadhi S. Daratumumab-lenalidomide and daratumumab-pomalidomide in relapsed lenalidomide-exposed or refractory multiple myeloma. Anticancer Drugs. 2024 Jan 1; 35 (1):63-69 Epub 2023 Apr 06
    View PubMed
  8. McCormick BJ, Zieman D, Sluzevich JC, Alhaj Moustafa M. Clinical Features of Cutaneous Paraneoplastic Syndromes in Hodgkin Lymphoma. J Investig Med High Impact Case Rep. 2024 Jan-Dec; 12:23247096241255840
    View PubMed
  9. Muhamad Alhaj Moustafa, Mario El Hayek. A Comprehensive Review of Monoclonal Antibodies for the Treatment of Follicular Lymphoma Including Both Approved and Investigational Options European Society of Medicine. 2023.
  10. Tama E, Black M, Moustafa MA, Hurtado MD. Severe Insulin Resistance in a Patient Treated With Nivolumab and Brentuximab-Vedotin for Hodgkin Lymphoma. JCEM Case Rep. 2023 Nov; 1 (6):luad121 Epub 2023 Nov 03
    View PubMed
  11. Saifi O, Breen WG, Lester SC, Rule WG, Stish BJ, Rosenthal A, Munoz J, Lin Y, Bansal R, Hathcock MA, Johnston PB, Ansell SM, Paludo J, Khurana A, Villasboas JC, Wang Y, Iqbal M, Moustafa MA, Murthy HS, Kharfan-Dabaja MA, Peterson JL, Hoppe BS. Consolidative radiotherapy for residual fluorodeoxyglucose activity on day +30 post CAR T-cell therapy in non-Hodgkin lymphoma. Haematologica. 2023 Nov 01; 108(11):2982-2992.
    View PubMed
  12. Saifi O, Breen WG, Lester SC, Rule WG, Stish BJ, Rosenthal A, Munoz J, Lin Y, Bansal R, Hathcock MA, Bennani NN, Paludo J, Khurana A, Villasboas JC, Johnston PB, Ansell SM, Iqbal M, Moustafa MA, Murthy HS, Kharfan-Dabaja MA, Hoppe BS, Peterson JL. Don't Put the CART Before the Horse: The Role of Radiation Therapy in Peri-CAR T-cell Therapy for Aggressive B-cell Non-Hodgkin Lymphoma. Int J Radiat Oncol Biol Phys. 2023 Aug 1; 116 (5):999-1007 Epub 2022 Dec 21
    View PubMed
  13. Chohan KL, Young JR, Lester S, Moustafa MA, Rosenthal A, Tun HW, Hoppe BS, Johnston PB, Micallef IN, Habermann TM, Ansell SM. End-of-treatment PET in early-stage Hodgkin lymphoma: valuable in addition to interim PET. Haematologica 2023 Jun 1; 108 (6):1697-1701 Epub 2023 June 01
    View PubMed
  14. Huntington SF, Schuster SJ, Ding W, Koehler AB, Brander DM, Rosenthal AC, Leis JF, Tun HW, Alhaj Moustafa M, Moustafa MA, Iqbal M, He W, Kearney AS, McKinlay TP, Gui M, Mato AR. DTRMWXHS-12, a novel Bruton tyrosine kinase inhibitor, in combination with everolimus and pomalidomide in patients with relapsed/refractory lymphomas: An open-label, multicenter, phase 1a/1b study. Am J Hematol. 2023 May; 98 (5):739-749 Epub 2023 Mar 07
    View PubMed
  15. Alhaj Moustafa M. Timing of CAR-T therapy in follicular lymphoma. Expert Rev Anticancer Ther 2023 Apr; 23 (4):347-349 Epub 2023 Mar 01
    View PubMed
  16. Alhaj Moustafa M, Borah BJ, Moriarty JP, Dholakia R, Jiang L, Li K, Witzig TE, Hoppe BS, Peterson J, Cerhan JR, Tun HW. Yttrium-90 Ibritumomab Tiuxetan is Cost-Effective Compared to Bendamustine + Rituximab in Low-grade Lymphomas. Clin Lymphoma Myeloma Leuk. 2023 Apr; 23 (4):259-265 Epub 2023 Jan 26
    View PubMed
  17. Iqbal M, Jiang L, Li KD, Moustafa MA, Kimbrough EO, Ansell SM, Tun HW. Poly-lymphomatous Syndrome With Concurrent or Sequential Hodgkin and Non-Hodgkin lymphoma. Clin Lymphoma Myeloma Leuk. 2023 Feb; 23 (2):138-144 Epub 2022 Nov 18
    View PubMed
  18. Butts E, Gococo-Benore D, Pai T, Moustafa MA, Heng F, Chen R, Zhao Y, Manochakian R, Lou Y. Brief report: risk stratification following curative therapy for stage I NSCLC. Front Oncol. 2023; 13:1250315. Epub 2023 Aug 14.
    View PubMed
  19. Fournier LL, Kimbrough EO, Alhaj Moustafa M, Li K, Iqbal M, Gupta V, Tun HW. Multiply Relapsed Secondary CNS Non-Germinal Center Diffuse Large B-Cell Lymphoma Successfully Treated with CNS-Centric Therapy. J Blood Med. 2023; 14:455-461. Epub 2023 Aug 16.
    View PubMed
  20. Wolf EB, Li D, Fernandez AJ, Gardner LB, Rivera CE, Wysokinska EM, Shaikh ME, Tun HW, Roy V, Alhaj Moustafa M. Acquired Factor VII Deficiency Associated With Chronic Myeloid Leukemia Blast Crisis. J Investig Med High Impact Case Rep. 2023 Jan-Dec; 11:23247096231209543.
    View PubMed
  21. Wang J, Baidoun F, Tun HW, Alhaj Moustafa M. 90Yttrium Ibritumomab Tiuxetan (Zevalin) for the Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Report of 5 Cases. Blood Lymphat Cancer. 2023; 13:59-65. Epub 2023 Oct 03.
    View PubMed
  22. Davis J, Kimbrough EO, Alhaj Moustafa M, Jiang L, Gupta V, Parent E, Tun HW. Successful CNS-Centric Therapeutic Management and Genomic Profiling of Primary Cranial Vault Diffuse Large B-Cell Lymphoma. J Blood Med. 2023; 14:49-55 Epub 2023 Jan 22
    View PubMed
  23. Kharfan-Dabaja MA, Yassine F, Alhaj Moustafa M, Moustafa MA, Iqbal M, Murthy H. Lisocabtagene Maraleucel in Relapsed or Refractory Diffuse Large B Cell Lymphoma: What is the Evidence? Hematol Oncol Stem Cell Ther. 2022 Dec 23; 15 (4):168-175
    View PubMed
  24. Mohty R, Moustafa MA, Aljurf M, Murthy H, Kharfan-Dabaja MA. Emerging Role of Autologous CD19 CAR T-Cell Therapies in the Second-Line Setting for Large B-cell Lymphoma: A Game Changer? Hematol Oncol Stem Cell Ther. 2022 Nov 07; 15(3):73-80.
    View PubMed
  25. Murthy HS, Yassine F, Iqbal M, Alotaibi S, Moustafa MA, Kharfan-Dabaja MA. Management of CAR T-cell Related Toxicities: What did the Learning Curve Teach us so Far? Hematol Oncol Stem Cell Ther. 2022 Nov 07; 15(3):100-111.
    View PubMed
  26. Ailawadhi S, Parrondo RD, Moustafa MA, LaPlant BR, Alegria V, Chapin D, Roy V, Sher T, Paulus A, Chanan-Khan AA. Ibrutinib, lenalidomide and dexamethasone in patients with relapsed and/or refractory multiple myeloma: Phase I trial results. Hematol Oncol. 2022 Oct; 40 (4):695-703 Epub 2022 May 08
    View PubMed
  27. Seegobin K, Li Z, Alhaj Moustafa M, Majeed U, Wang J, Jiang L, Kuhlman J, Menke D, Li K, Kharfan-Dabaja MA, Ayala E, Iqbal M, Nowakowski GS, Habermann TM, Witzig TE, Johnston P, Thompson C, Ansell S, Tun HW. Clinical characteristics, prognostic indicators, and survival outcomes in intravascular lymphoma: Mayo Clinic experience (2003-2018). Am J Hematol. 2022 Sep; 97 (9):1150-1158 Epub 2022 July 06
    View PubMed
  28. Alhaj Moustafa M, Peterson J, Hoppe BS, Jiang J, Wiseman GA, Witzig TE, Tun HW. Real World Long-term Follow-up Experience with Yttrium-90 ibritumomab tiuxetan in Previously Untreated Patients with Low-Grade Follicular Lymphoma and Marginal Zone Lymphoma. Clin Lymphoma Myeloma Leuk. 2022 Aug; 22 (8):618-625 Epub 2022 Mar 17
    View PubMed
  29. Kuhlman JJ, Moustafa MA, Jiang L, Iqbal M, Seegobin K, Wolcott Z, Ayala E, Ansell S, Rosenthal A, Paludo J, Micallef I, Johnston P, Inwards D, Habermann T, Kharfan-Dabaja M, Witzig TE, Nowakowski GS, Tun HW. Leukemic High Grade B Cell Lymphoma is Associated With MYC Translocation, Double Hit/Triple Hit Status, Transformation, and CNS Disease Risk: The Mayo Clinic Experience. Clin Lymphoma Myeloma Leuk. 2022 Aug; 22 (8):e815-e825 Epub 2022 Apr 14
    View PubMed
  30. Chohan KL, Young JR, Lester S, Alhaj Moustafa M, Rosenthal A, Tun HW, Hoppe BS, Johnston PB, Micallef IN, Habermann TM, Ansell SM. A real-world study of combined modality therapy for early-stage Hodgkin lymphoma: too little treatment impacts outcome. Blood Adv. 2022 Jul 26; 6 (14):4241-4250
    View PubMed
  31. Baidoun F, Moustafa MA, Tun HW, Hill BT. Clinical Characteristics and Survival Outcomes of Primary Effusion Lymphoma: A National Cancer Database Study. Clin Lymphoma Myeloma Leuk. 2022 Jul; 22 (7):e485-e494 Epub 2022 Jan 14
    View PubMed
  32. Cortes P, Ghoz HM, Mzaik O, Alhaj Moustafa M, Bi Y, Brahmbhatt B, Daoud N, Pang M. Colchicine as an Alternative First-Line Treatment of Sclerosing Mesenteritis: A Retrospective Study. Dig Dis Sci. 2022 Jun; 67 (6):2403-2412 Epub 2021 June 04
    View PubMed
  33. Baidoun F, Sarmini MT, Merjaneh Z, Moustafa MA. Controversial risk factors for cholangiocarcinoma. Eur J Gastroenterol Hepatol. 2022 Mar 1; 34 (3):338-344
    View PubMed
  34. Yassine F, Reljic T, Moustafa MA, Alhaj Moustafa M, Iqbal M, Murthy HS, Kumar A, Kharfan-Dabaja MA. Efficacy of Allogeneic Hematopoietic Cell Transplantation in Patients With Chronic Phase CML Resistant or Intolerant to Tyrosine Kinase Inhibitors. Hematol Oncol Stem Cell Ther. 2022 Mar 1; 15 (1):36-43 Epub 2022 Mar 01
    View PubMed
  35. Iqbal M, Castano YG, Paludo J, Rosenthal A, Li Z, Beltran M, Moustafa MA, Inwards D, Porrata L, Micallef I, Bisneto JCV, Johnston P, Ansell SM, Reeder C, Murthy H, Roy V, Foran J, Tun HW, Kharfan-Dabaja MA, Ayala E. Impact of Cell of Origin on Outcomes After Autologous Hematopoietic Cell Transplant in Diffuse Large B-Cell Lymphoma. Clin Lymphoma Myeloma Leuk. 2022 Feb; 22 (2):e89-e95 Epub 2021 Aug 31
    View PubMed
  36. Baksh M, Li K, Jiang L, Alegria V, Sher T, Roy V, Chanan-Khan A, Ailawadhi S, Parrondo RD, Alhaj Moustafa M. Myelomatous ascites and pleural effusion in relapsed multiple myeloma. Clin Case Rep. 2022 Feb; 10 (2):e05329 Epub 2022 Feb 02
    View PubMed
  37. Kuhlman JJ, Alhaj Moustafa M, Jiang L, Wang J, Gupta V, Tun HW. Long-Term Survival with Ibrutinib Therapy in Elderly Patients with Newly Diagnosed Primary Central Nervous System Lymphoma. Blood Lymphat Cancer. 2022; 12:23-29 Epub 2022 Apr 14
    View PubMed
  38. Wang J, Alhaj Moustafa M, Kuhlman JJ, Seegobin K, Jiang L, Gupta V, Tun HW. Intravascular Large B Cell Lymphoma with CNS Involvement Successfully Treated with High-Dose Methotrexate and High-Dose Ara-C Based CNS-Directed Chemoimmunotherapy Alternating with Anthracycline Based Chemoimmunotherapy. Blood Lymphat Cancer. 2022; 12:47-54 Epub 2022 May 25
    View PubMed
  39. Kase AM, Bullock C, Parrondo R, Alhaj Moustafa M, Iqbal M, Li KD, Parent EE, Tun H. Neuropsychiatric Manifestations of Lymphoma-Associated Cerebral Glucose Hypometabolism Can Be Reversed by Intensive Glucose Supplementation. Blood Lymphat Cancer. 2022; 12:17-21 Epub 2022 Mar 23
    View PubMed
  40. Kimbrough EO, Jiang L, Parent EE, Bourgeois K, Alhaj Moustafa M, Tun HW, Iqbal M. Primary Bone Marrow Lymphoma: De Novo and Transformed Subtypes. J Blood Med. 2022; 13:663-671. Epub 2022 Nov 14.
    View PubMed
  41. Desai S, Moustafa MA, Wiseman G, Witzig T. Ibritumomab Tiuxetan Radioimmunotherapy for Primary Gastrointestinal Follicular Lymphoma. Oncologist. 2021 Nov; 26 (11):e2079-e2081 Epub 2021 July 21
    View PubMed
  42. Abedin S, Rashid N, Schroeder M, Romee R, Nauffal M, Alhaj Moustafa M, Kharfan-Dabaja MA, Palmer J, Hogan W, Hefazi M, Larson S, Holtan S, DeFilipp Z, Jayani R, Dholaria B, Pidala J, Khimani F, Grunwald MR, Butler C, Hamadani M. Ruxolitinib resistance or intolerance in steroid-refractory acute graft-versus-host disease - a real-world outcomes analysis. Br J Haematol. 2021 Nov; 195 (3):429-432 Epub 2021 July 12
    View PubMed
  43. Saifi O, Lester SC, Rule W, Stish BJ, Stafford S, Pafundi DH, Jiang L, Menke D, Moustafa MA, Rosenthal A, Sher T, Ernesto A, Tun HW, Hoppe BS, Peterson JL. Comparable Efficacy of Reduced Dose Radiation Therapy for the Treatment of Early Stage Gastric Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue. Adv Radiat Oncol. 2021 Jul-Aug; 6 (4):100714 Epub 2021 May 08
    View PubMed
  44. Kuhlman JJ, Alhaj Moustafa M, Tun AJ, Menke DM, Tun HW, Jiang L. Primary age-related EBV-associated effusion-based lymphoma successfully treated with rituximab and thoracentesis. Clin Case Rep. 2021 May; 9 (5):e03971 Epub 2021 Apr 04
    View PubMed
  45. Parrondo RD, Moustafa MA, Reeder C, Sher T, Roy V, Muchtar E, Warsame R, Alegria V, Gonsalves W, Dingli D, Hayman S, Kapoor P, Chanan-Khan AA, Ailawadhi S. Efficacy of Daratumumab-Based Regimens for the Treatment of Plasma Cell Leukemia. Clin Lymphoma Myeloma Leuk. 2021 May; 21 (5):355-360 Epub 2021 Jan 12
    View PubMed
  46. Seegobin K, Moustafa MA, Gannon N, Keller K, Hastings J, Gupta V, Tun HW, Jiang L. Successful treatment of IgG4-related hypertrophic pachymeningitis with induction rituximab and dexamethasone followed by maintenance rituximab. Clin Case Rep. 2021 Mar; 9 (3):1610-1614 Epub 2021 Jan 27
    View PubMed
  47. Bojanini L, Jiang L, Tun AJ, Ayala E, Menke DM, Hoppe B, Kharfan-Dabaja MA, Tun HW, Alhaj Moustafa M. Outcomes of Hepatosplenic T-Cell Lymphoma: The Mayo Clinic Experience. Clin Lymphoma Myeloma Leuk. 2021 Feb; 21 (2):106-112.e1 Epub 2020 Oct 05
    View PubMed
  48. Seegobin K, Alhaj Moustafa M, Majeed U, Ray JC, Shaikh M, Jiang L, Tun HW. Macrophage Activation Led Acute Heart Failure Managed Successfully with Immunosuppression. J Blood Med. 2021; 12:1037-1043 Epub 2021 Dec 07
    View PubMed
  49. Kuhlman J, Alhaj Moustafa M, Jiang L, Tun HW. Primary HHV-8 (-) Effusion-Based Non-Germinal Center B Cell Diffuse Large B Cell Lymphoma Successfully Treated with Standard Anthracycline-Based Chemoimmunotherapy. J Blood Med. 2021; 12:833-838 Epub 2021 Sept 09
    View PubMed
  50. Seegobin K, Alhaj Moustafa M, Jiang L, Tun HW. Successful Non-Transplant Treatment of Double Hit Richter Transformation with Long-Term Remission. Blood Lymphat Cancer. 2021; 11:67-72 Epub 2021 Sept 22
    View PubMed
  51. Alhaj Moustafa M, Jiang L, Kuhlman JJ, Jones J, Lou Y, Sokumbi O, Tun HW. BRAF p.V600E associated poly-neoplastic syndrome. Rare Tumors. 2021; 13:20363613211012929 Epub 2021 Apr 27
    View PubMed
  52. Kuhlman JJ, Alhaj Moustafa M, Gupta V, Jiang L, Tun HW. Primary Cauda Equina Lymphoma Treated with CNS-Centric Approach: A Case Report and Literature Review. J Blood Med. 2021; 12:645-652 Epub 2021 July 21
    View PubMed
  53. Seegobin K, Alhaj Moustafa M, Fischer D, Keller K, Hastings J, Kharfan-Dabaja MA, Ayala E, Gupta V, Tun HW, Jiang L. Systemic ALK-positive anaplastic large cell lymphoma with bilateral optic neurolymphomatosis resulting in permanent blindness. Clin Case Rep. 2020 Dec; 8 (12):2629-2633 Epub 2020 Aug 14
    View PubMed
  54. Melody M, Parrondo R, Alhaj Moustafa M, Wu K, Menke D, Seim L, Tun HW. Follicular lymphoma associated paraneoplastic myositis. Clin Case Rep. 2020 Oct; 8 (10):2003-2006 Epub 2020 July 23
    View PubMed
  55. Kumar V, Alhaj-Moustafa M, Bojanini L, Sher T, Roy V, Manochakian R, Vishnu P, Bodepudi S, Shareef Z, Ahmed S, Jani P, Paulus A, Grover A, Alegria VR, Ailawadhi M, Chanan-Khan A, Ailawadhi S. Timeliness of Initial Therapy in Multiple Myeloma: Trends and Factors Affecting Patient Care. JCO Oncol Pract. 2020 Apr; 16 (4):e341-e349 Epub 2020 Jan 21
    View PubMed
  56. Fernandez Turizo MJ, Kharfan-Dabaja MA, Alhaj Moustafa M, Ayala E, Jiang L, Parrondo R. Primary diffuse large B-cell lymphoma presenting as acute appendicitis: A report of 2 cases and a literature review. Clin Case Rep. 2020 Feb; 8 (2):293-298 Epub 2020 Jan 07
    View PubMed
  57. Mirza MU, Van Taunay J, Waleed M, Vangimalla SS, Hegde S, Moustafa MA. Xanthogranulomatous Pyelonephritis: Synchronous Upper and Lower Gastrointestinal Bleed. J Investig Med High Impact Case Rep. 2019 Jan-Dec; 7:2324709619842899
    View PubMed
  58. Alhaj Moustafa M, Alhaj Moustafa A, Elmahdy S. A Mysterious Calcified Target Lesion Causing Gastrointestinal Bleeding. Gastroenterology. 2018 Dec; 155 (6):1697-1698 Epub 2018 July 19
    View PubMed
  59. Alhaj Moustafa M, Crowell EL, Elmahdy S, Malkovska V, Reddy AK. Paraneoplastic frosted branch angiitis as first sign of relapsed Hodgkin lymphoma. Clin Case Rep. 2018 Oct; 6 (10):1978-1981 Epub 2018 Aug 29
    View PubMed
  60. Muhailan Mohamad, Alhaj Muhamad. Medical Image of the Week: Malposition of Central Venous Catheter Southwest Journal of Pulmonary and Critical Care. 2018.
  61. Vakiti A, Pilla R, Alhaj Moustafa M, Joseph JJ, Shenoy AG. Ifosfamide-Induced Metabolic Encephalopathy in 2 Patients With Cutaneous T-Cell Lymphoma Successfully Treated With Methylene Blue. J Investig Med High Impact Case Rep. 2018 Jan-Dec; 6:2324709618786769 Epub 2018 July 06
    View PubMed
  62. Elmahdy S, Shults CC, Alhaj Moustafa M. An Unusual Cause of Acute Heart Failure: A Case Report of Iliocaval Venous Stent Migration. J Investig Med High Impact Case Rep. 2018 Jan-Dec; 6:2324709618799118 Epub 2018 Sept 07
    View PubMed
  63. Vakiti A, Singh D, Pilla R, Alhaj-Moustafa M, Fitzpatrick KW. Bevacizumab-induced atypical hemolytic uremic syndrome and treatment with eculizumab. J Oncol Pharm Pract. 2018 Jan 1; 1078155218774895 Epub 2018 Jan 01
    View PubMed
  64. Lakshman A, Alhaj Moustafa M, Rajkumar SV, Dispenzieri A, Gertz MA, Buadi FK, Lacy MQ, Dingli D, Fonder AL, Hayman SR, Hobbs MA, Gonsalves WI, Hwa YL, Kapoor P, Leung N, Go RS, Lin Y, Kourelis TV, Lust JA, Russell SJ, Zeldenrust SR, Kyle RA, Kumar SK. Natural history of t(11;14) multiple myeloma. Leukemia. 2018 Jan; 32(1):131-138. Epub 2017 Jun 27.
    View PubMed
  65. Alhaj Moustafa M, Malkovska V, Elmahdy S, Catlett J. A Challenging Case of Pseudohyperkalemia in Chronic Lymphocytic Leukemia. J Investig Med High Impact Case Rep. 2017 Oct-Dec; 5 (4):2324709617746194 Epub 2017 Dec 13
    View PubMed
  66. Alhaj Moustafa M, Rajkumar SV, Dispenzieri A, Gertz MA, Lacy MQ, Buadi FK, Hwa YL, Dingli D, Kapoor P, Hayman SR, Lust JA, Kyle RA, Kumar SK. Utility of serum free light chain measurements in multiple myeloma patients not achieving complete response to therapy. Leukemia. 2015 Oct; 29 (10):2033-8 Epub 2015 May 12
    View PubMed
  67. Moustafa MA, Seningen JL, Moustafa MA, Jouni H, Singh PP, el-Azhary RA, Witzig TE. A skin rash and what lies beneath: paraneoplastic pemphigus, an atypical presentation of follicular cell lymphoma. Am J Hematol. 2013 Sep; 88 (9):822-3 Epub 2013 Aug 05
    View PubMed
  68. Alhaj Moustafa M, Seningen JL, Jouni H. Hypercalcemia, Renal Failure, and Skull Lytic Lesions: Follicular Lymphoma Masquerading as Multiple Myeloma. J Investig Med High Impact Case Rep. 2013 Apr-Jun; 1 (2):2324709613486356 Epub 2013 Apr 12
    View PubMed